We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+17.28%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$942M
AUM Growth
+$65.9M
Cap. Flow
-$40.6M
Cap. Flow %
-4.31%
Top 10 Hldgs %
17.62%
Holding
1,095
New
434
Increased
124
Reduced
144
Closed
391

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$20.3M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.1M
3
QCOM icon
Qualcomm
QCOM
+$13.7M
4
DDOG icon
Datadog
DDOG
+$9.59M
5
XOM icon
ExxonMobil
XOM
+$8.72M

Sector Composition

Rank Sector Weight
1 Technology 26.27%
2 Consumer Discretionary 12.98%
3 Healthcare 12.92%
4 Financials 8.55%
5 Industrials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMT
551
PennyMac Mortgage Investment
PMT
$817M
$250K 0.03%
+16,700
New +$224K
IAS
552
DELISTED
Integral Ad Science
IAS
$249K 0.03%
17,300
+5,700
+49% +$76.3K
GPCR icon
553
Structure Therapeutics
GPCR
$3.38B
$248K 0.03%
+6,086
New +$349K
DPZ icon
554
Domino's
DPZ
$11.6B
$247K 0.03%
+599
New +$225K
FTDR icon
555
Frontdoor
FTDR
$5.65B
$245K 0.03%
6,957
-14,521
-68% -$483K
PKX icon
556
POSCO
PKX
$18.1B
$241K 0.03%
+2,536
New +$229K
AGIO icon
557
Agios Pharmaceuticals
AGIO
$2B
$241K 0.03%
+10,800
New +$242K
NSIT icon
558
Insight Enterprises
NSIT
$4.57B
$239K 0.03%
+1,349
New +$210K
FLGT icon
559
Fulgent Genetics
FLGT
$538M
$239K 0.03%
+8,265
New +$221K
SGRY icon
560
Surgery Partners
SGRY
$1.81B
$236K 0.03%
+7,386
New +$214K
BLBD icon
561
Blue Bird Corp
BLBD
$1.86B
$236K 0.03%
+8,752
New +$180K
EVTC icon
562
Evertec
EVTC
$1.79B
$235K 0.03%
+5,751
New +$211K
EPC icon
563
Edgewell Personal Care
EPC
$1.33B
$234K 0.02%
+6,400
New +$226K
PHG icon
564
Philips
PHG
$26.1B
$234K 0.02%
+11,224
New +$204K
SWTX
565
DELISTED
SpringWorks Therapeutics
SWTX
$234K 0.02%
+6,398
New +$167K
AOS icon
566
A.O. Smith
AOS
$8.13B
$231K 0.02%
2,807
-4,508
-62% -$332K
GBX icon
567
The Greenbrier Companies
GBX
$1.41B
$231K 0.02%
+5,228
New +$204K
TTEK icon
568
Tetra Tech
TTEK
$9.4B
$231K 0.02%
6,910
-1,200
-15% -$38.3K
CC icon
569
Chemours
CC
$2.35B
$228K 0.02%
+7,214
New +$196K
CMS icon
570
CMS Energy
CMS
$21.5B
$226K 0.02%
3,900
-51,223
-93% -$2.86M
AVD icon
571
American Vanguard Corp
AVD
$64.6M
$226K 0.02%
+20,607
New +$205K
HE icon
572
Hawaiian Electric Industries
HE
$1.98B
$226K 0.02%
+15,920
New +$207K
PUBM icon
573
PubMatic
PUBM
$785M
$226K 0.02%
+13,836
New +$201K
AMAM
574
DELISTED
Ambrx Biopharma Inc
AMAM
$225K 0.02%
+15,804
New +$180K
ACH
575
Accendra Health
ACH
$93.8M
$224K 0.02%
+11,632
New +$211K

Similar funds

Bayesian Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Bayesian Capital Management held 1,095 positions worth $942M, up 7.5% from $876M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Bayesian Capital Management withdrew a net $40.6M in Q4 2023, closing 391 positions and reducing 144 holdings. Its most notable exit was Palo Alto Networks, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $21.5M.

  • Bayesian Capital Management's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 45,200 shares worth $21.5M.
  • Bayesian Capital Management added most to Alibaba in Q4 2023, an estimated $20.3M increase.
  • Bayesian Capital Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $18.9M.
  • Bayesian Capital Management fully exited Palo Alto Networks in Q4 2023, selling an estimated $20M.
  • Bayesian Capital Management's ten largest holdings make up 18% of its $942M portfolio in Q4 2023.
  • Bayesian Capital Management opened 434 new positions and closed 391 in Q4 2023.
  • Bayesian Capital Management's portfolio value rose 7.5% quarter-over-quarter to $942M.

Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.